Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target

Author： Zeng Lingchun Imamoto Akira Rosner Marsha Rich

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.10, 2008-10, pp. : 1275-1287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular FLICE-inhibitory protein: an attractive therapeutic target?

By Micheau Olivier

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 4, 2003-08 ,pp. : 559-573

Informa Healthcare

Access to resources Recommend Favorite

Death associated protein kinase as a potential therapeutic target

By Schumacher Andrew M Velentza Anastasia V Watterson D Martin

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 497-506

Informa Healthcare

Access to resources Recommend Favorite

Rationale for Ras and Raf-kinase as a Target for Cancer Therapeutics

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2231-2242

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer

By Browning Darren D

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 367-376

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 655-664

Bentham Science Publishers

Access to resources Recommend Favorite